Controlled DCD heart re-transplantation enabled by ex-situ normothermic perfusion: First UK case and implications for

Patrick Cannon1, Jonathan R Dalzell2, Hari Doshi2

  • 1University of Glasgow, Glasgow, UK.

Perfusion
|May 25, 2026
PubMed

Insights

This study reports the first UK cardiac re-transplantation using a donor heart from donation after circulatory death (DCD) preserved with normothermic perfusion, following primary graft failure.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Organ Donation

Background:

  • Cardiac re-transplantation is infrequent and associated with high peri-operative risks.
  • Donation after circulatory death (DCD) donors, preserved with ex-situ normothermic perfusion, are increasingly used, expanding the donor pool.
  • Experience with DCD donors in cardiac re-transplantation remains limited.

Purpose of the Study:

  • To describe the first UK case of orthotopic heart re-transplantation using a controlled DCD donor.
  • To evaluate the use of ex-situ normothermic perfusion for preserving a DCD heart for re-transplantation.
  • To report outcomes following re-transplantation for primary graft failure.

Main Methods:

  • Orthotopic heart re-transplantation was performed using a controlled DCD donor heart.
  • The donor heart was preserved using ex-situ normothermic perfusion.
  • The recipient had experienced severe irrecoverable primary graft failure 140 days post-index transplantation.

Main Results:

  • Successful orthotopic heart re-transplantation was achieved using a DCD donor heart preserved with normothermic perfusion.
  • This represents the first reported case in the UK utilizing this specific donor type and preservation method for cardiac re-transplantation.
  • The patient presented with severe early graft dysfunction involving both ventricles, meeting criteria for primary graft failure.

Conclusions:

  • Ex-situ normothermic perfusion of controlled DCD donor hearts is a viable option for cardiac re-transplantation.
  • This case expands the evidence base for using DCD donors in complex cardiac re-transplantation scenarios.
  • Further research is warranted to establish the long-term outcomes and safety of this approach.